(Reuters) - A combination of five oral drugs being tested by AbbVie Inc cured at least 88 percent of new patients with hepatitis C after only eight weeks of treatment, ...
Read more
(Reuters) - A federal health advisory panel in June will reconsider safety data on GlaxoSmithKline Plc's Avandia diabetes drug, although the British drugmaker on Friday said it has not sought ...
Read more
(Reuters) - Johnson & Johnson reported better-than-expected fourth-quarter earnings on Tuesday, but took another big special charge for its recalled artificial hips and forecast 2013 earnings below Wall Street forecasts.The ...
Read more
NEW YORK (Reuters) - Eli Lilly & Co may have a $15 billion wild card up its sleeve as it waits for desperately needed new drugs to bear fruit.Should an ...
Read more
(Reuters) - Drugmaker Eli Lilly & Co is confident it will do for Alzheimer's patients what it did almost a century ago for diabetics - find a breakthrough treatment, even ...
Read more
(Reuters) - Levels of a protein believed to be a main cause of Alzheimer's disease rose in the blood of patients treated with Eli Lilly's experimental drug in late-stage trials, ...
Read more
